New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Study shows protein inhibitor as potential treatment approach for common mutations found in non-Hodgkin lymphomas

Study shows protein inhibitor as potential treatment approach for common mutations found in non-Hodgkin lymphomas

byUniversity of Texas M. D. Anderson Cancer CenterCancer cell during cell division. Credit: National Institutes of HealthA study at The University of Texas MD Anderson Cancer Center demonstrated
Oncology December 22,2023
Study shows protein inhibitor as potential treatment approach for common mutations found in non-Hodgkin lymphomas

Study shows protein inhibitor as potential treatment approach for common mutations found in non-Hodgkin lymphomas

byUniversity of Texas M. D. Anderson Cancer CenterCancer cell during cell division. Credit: National Institutes of HealthA study at The University of Texas MD Anderson Cancer Center demonstrated
Oncology December 22,2023
Study finds novel molecular therapeutic target for colon cancer

Study finds novel molecular therapeutic target for colon cancer

byBoston University School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers have found a way to help make chemotherapy more effective in treating col
Oncology December 22,2023
Study finds novel molecular therapeutic target for colon cancer

Study finds novel molecular therapeutic target for colon cancer

byBoston University School of MedicineCancer cell during cell division. Credit: National Institutes of HealthResearchers have found a way to help make chemotherapy more effective in treating col
Oncology December 22,2023
Breaking down proteins: How starving cancer cells switch food sources

Breaking down proteins: How starving cancer cells switch food sources

byGerman Cancer Research CenterHuman cancer cells (cell nucleus in blue) feeding on protein (Albumin, labeled in green). The proteins are digested and broken down into amino acids in the lysosom
Oncology December 22,2023
Breaking down proteins: How starving cancer cells switch food sources

Breaking down proteins: How starving cancer cells switch food sources

byGerman Cancer Research CenterHuman cancer cells (cell nucleus in blue) feeding on protein (Albumin, labeled in green). The proteins are digested and broken down into amino acids in the lysosom
Oncology December 22,2023
Unfruitful: Eating more produce will not cure, stop prostate cancer

Unfruitful: Eating more produce will not cure, stop prostate cancer

byUniversity of California - San DiegoMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0National guidelines recomme
Oncology December 22,2023
Unfruitful: Eating more produce will not cure, stop prostate cancer

Unfruitful: Eating more produce will not cure, stop prostate cancer

byUniversity of California - San DiegoMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0National guidelines recomme
Oncology December 22,2023
New mechanism of radioresistance formation shown in lung adenocarcinoma

New mechanism of radioresistance formation shown in lung adenocarcinoma

by Zhang Nannan,Chinese Academy of SciencesGOLPH3 mediates radioresistance formation of lung adenocarcinoma. Credit: Kong PeizhongA research team led by Prof. Han Wei from the Hefei Institutes o
Oncology December 22,2023
New mechanism of radioresistance formation shown in lung adenocarcinoma

New mechanism of radioresistance formation shown in lung adenocarcinoma

by Zhang Nannan,Chinese Academy of SciencesGOLPH3 mediates radioresistance formation of lung adenocarcinoma. Credit: Kong PeizhongA research team led by Prof. Han Wei from the Hefei Institutes o
Oncology December 22,2023
Prostate cancer can now be diagnosed better using artificial intelligence

Prostate cancer can now be diagnosed better using artificial intelligence

byRadboud UniversityMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Researchers at Radboud university medical cen
Oncology December 22,2023
Prostate cancer can now be diagnosed better using artificial intelligence

Prostate cancer can now be diagnosed better using artificial intelligence

byRadboud UniversityMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Researchers at Radboud university medical cen
Oncology December 22,2023
Researchers uncover new vulnerability in kidney cancer

Researchers uncover new vulnerability in kidney cancer

by Deborah Wormser,UT Southwestern Medical CenterFrom left: Drs. Lianxin Hu, Qing Zhang, and Haibiao Xie Credit: UTSWA UT Southwestern researcher led a team that identified a new vulnerability i
Oncology December 22,2023
Researchers uncover new vulnerability in kidney cancer

Researchers uncover new vulnerability in kidney cancer

by Deborah Wormser,UT Southwestern Medical CenterFrom left: Drs. Lianxin Hu, Qing Zhang, and Haibiao Xie Credit: UTSWA UT Southwestern researcher led a team that identified a new vulnerability i
Oncology December 22,2023
The obesity paradox in lung cancer diagnosis may differ by race

The obesity paradox in lung cancer diagnosis may differ by race

by Makhari Dysart,Thomas Jefferson UniversityCredit: Pixabay/CC0 Public DomainLung cancer is the leading cause of cancer death in the U.S., making up 25% of cancer deaths. With obesity rates sim
Oncology December 22,2023
The obesity paradox in lung cancer diagnosis may differ by race

The obesity paradox in lung cancer diagnosis may differ by race

by Makhari Dysart,Thomas Jefferson UniversityCredit: Pixabay/CC0 Public DomainLung cancer is the leading cause of cancer death in the U.S., making up 25% of cancer deaths. With obesity rates sim
Oncology December 22,2023
New compounds block master regulator of cancer growth, metastasis

New compounds block master regulator of cancer growth, metastasis

by Diana Yates,University of Illinois at Urbana-ChampaignResearchers including, from left, graduate student Valeria Sanabria Guillen, research scientist Sung Hoon Kim, researcher Kathy Carlson,
Oncology December 22,2023
New compounds block master regulator of cancer growth, metastasis

New compounds block master regulator of cancer growth, metastasis

by Diana Yates,University of Illinois at Urbana-ChampaignResearchers including, from left, graduate student Valeria Sanabria Guillen, research scientist Sung Hoon Kim, researcher Kathy Carlson,
Oncology December 22,2023
Lung cancer study finds new target for treatment resistance after EGFR inhibitors

Lung cancer study finds new target for treatment resistance after EGFR inhibitors

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainResearchers at The University of Texas MD Anderson Cancer Center have identified CD70 as being highly expressed
Oncology December 22,2023
Lung cancer study finds new target for treatment resistance after EGFR inhibitors

Lung cancer study finds new target for treatment resistance after EGFR inhibitors

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainResearchers at The University of Texas MD Anderson Cancer Center have identified CD70 as being highly expressed
Oncology December 22,2023
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com